46
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Synthesis, fabrication and properties research of CS-mPEG-AN nanocomposite

, , , , , , , , & show all
Pages 37-50 | Received 24 Jun 2021, Accepted 20 Feb 2022, Published online: 26 Jul 2022
 

Abstract

A novel nanocomposite based on 3-(9-Anthryl)acrolein (AN) grafted onto mPEG-OOH carboxlyated Chitosan (CS-mPEG-AN) was prepared. The composites were further characterized by ultraviolet (UV), fluorescent spectrum, X-ray diffraction (XRD) and nuclear magnetic resonance (NMR). It has been demonstrated that the composite formed by ester bond and imine linkages. The powder of CS-mPEG-AN exhibit regular ellipsoid shapes. Fluorescent effect of the composite can be quenched by carbon nanotubes (CNTs) with concentration dependence. Nanoparticles of CS-mPEG-AN obtained by direct drying takes cubic shapes with SEM observation. The drug encapsulation and loading efficiency for paclitaxel (PTX) will up to 67.2% and 44.8% by 1:2 feed ratio of CS-mPEG-AN/PTX. In vitro drug release of PTX from the CS-mPEG-AN take 47.0% in acid (pH 5.0) and 27% in basic (pH 7.4) environments. The proposed CS-mPEG-AN composite and nanoparticles have the potential for application in the field of photoelectron transfer and drug delivery.

Additional information

Funding

Thanks to NSF of Chongqing (cstc2019jscx-msxm0366), Open Fund of Chongqing Key Laboratory of Industrial Fermentation Microorganism (GYFJWSW-201905), Project of Scientific and Technological Research Program of Chongqing Municipal Education Commission (KJZD-K201806401, KJZD-K201906401, KJQN201801528) and graduate Innovation Fund of CQUST (YKJCX2020509, YKJCX2120502, YKJCX2120541, 202111551006).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.